Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

SEARCH GUIDE  Download Search Tip PDF File

  • articleNo Access

    Industry Watch

      CSL Focuses on Plasma Industry.

      First Cancer Gene Therapy Approved in China.

      Top 100 Chinese Medical Enterprises in 2003.

      GlaxoSmithKline Launches New Cancer and Heart Disorder Drugs.

    • articleNo Access

      Industry Watch

        Xenome's Xen2174 Enters Human Clinical Trials.

        CyGenics Renewed NIH Contract on T Cell Technology.

        Novogen's Cardiovascular Drug Enters Human Clinical Trial.

        Rockeby's CANDIA5 Completed FDA 510K Trial.

        AustCancer's Revisys Supplements Coming to Singapore.

        Life Therapeutics and UK BioProducts in Negotiation for Anti-D Product.

        CSL To Distribute Acrux's MDTS for Female Testosterone Treatment.

        Indian Biotech Industry Needs More Mature Funding.

        Ocimum Licensed Biotracker to ARIUS Research.

        Lupin to Shut Down Its South African Subsidiary.

        Sinomem Ties Up with Local University in Membrane Work.

        SciGen to Market SciLin in India.

      • articleNo Access

        Industry Watch

          Agenix Completes $10.3 million Capital Raising.

          CSL Begins Human Trials of Prototype Bird Flu Vaccine.

          The People's Republic of China Ministry of Commerce Approves Beijing Med-Pharm's Acquisition of Beijing Wanwei Pharmaceutical Co.

          Lupin Enters into an Agreement with GSK Philippines for TB drugs.

          BioWa Inc Licenses Anti-FGF8 Antibody from Kyowa Hakko Kogyo Co Ltd.

          Japan's Eisai Collaborates with Sweden's BioArctic.

          Fluidigm Opens Singapore's First Biochip Fab.

          Low Dose Oral Interferon as Potential Therapy for Avian Flu.

        • articleNo Access

          Industry Watch

            Clinigene and SCIREX Cooperate on Global Clinical Trials.

            CSL Announces New Share Buyback.

            International Alliance Between ChemGenex and Stragen Pharma.

            Mayne Pharma Expands in Europe.

            Bausch & Lomb Acquires Shandong Chia Tai Freda Pharma.

            Eli Lilly Collaborates with Taisho Pharma.

            Pingchuan Signs Purchase and Sales Agreement with Sinopharm.

            Vietnam to Begin Animal Testing of VIRA 38.

            NIRS and Toshiba Medical Systems Develop a New 4-D Medical Imaging Device.

            Medipost—First Biotech Company to List on the Korea Stock Exchange.

            Korea Plans First Stem Cell Hospital.

            Bio-Diagnostic Commercializes Rapid Diagnostic Kits for Infectious Diseases.

            INS Bioscience Expands to China, US and West Asia.

            Neuren Teams up with Walter Reed Army Institute of Research.

            Paradigm Signs Licensing and Collaborating Deal with Ortho-McNeil.

            Paradigm and Takeda Enter Into CNS Therapeutics Alliance.

          • articleNo Access

            BioBoard

              University of Queensland Offers Biotech Scholarship to Indian Students.

              Australian Government Contributes $50M to Walter and Eliza Hall Institute.

              US Pharmacy Giant MedicineShoppe Opens its First Store in China's ChongQing.

              Pall Life Science Sets up Proteomics Center at Bangalore.

              Hong Kong and Guangdong Health Experts to Collaborate on Bird Flu Lab Testing.

              Taiwan's Vita Genomics, Yang Ming University and India's IGIB Sign Agreement on Liver Disease Research.

              Update on Bird flu.

              Singapore Scientists Make Discoveries on Stomach Cancer.

              US Imalux Corporation Inks Distribution Deals with Beijing Goodwell Company Limited.

              Australia's CSL Expansion Facility and Vaccine Market.

              India and the US Collaborate on Agriculture.

              Korea's Professor Hwang's Fabrication of Embryonic Stem Cell Research.

              Cygenics Awarded Another Patent.

            • articleNo Access

              Industry Watch

                EvoGenix and CSL Partner on Antibodies.

                Minomic's Business.

                Japan's Bioventures Today—OMAb Pharma K.K.

                Immunodiagnostic Systems—Signs Marketing and Sales Agreement with Medical & Biological laboratories.

                Vical and Anges MG to Collaborate on Allovectin-7.

                GlaxoSmithKline Strengthens Asian Presence with New S$300M Vaccine Plant.

                Kalbe Farma Sets up R&D Base in Singapore to Focus on Drug Development of Biopharmaceuticals.

                MerLion Pharma and ICES Inks R&D Partnership to Boost Singapore's Biotechnology Industry.

                Philips Inaugurates Asia Pacific's First Medical Learning Center.

              • chapterNo Access

                Analyzing the Role of Agency in Second Language Acquisition: A Case Study of Learning Chinese as a Second Language

                The purpose of this study is to explore the role of agency when L2 learners are learning Chinese as a second language (CSL). Agency, broadly defined as the ability to take actions with intentions, has become a research focus in language pedagogy. The results show that the personal background of L2 learners have some moderate impacts on their learning intentions and practical actions. The study also found that intentions and actions of L2 learners are highly correlated, which may provide some practical guidelines for potential practitioners as a reference.